Drug Trial Radar · NCT00721279
Sifrol (Pramipexole) Onset of Action and Impact: a 12-weeks Observational Study in Patients With Primary Restless Legs Syndrome
Last checked: Nov 19, 2026Latest source record: Jun 4, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
549
Actual
Start
Sep 2007
Primary completion
Oct 2008
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- Jul 24, 2008
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objectives of the Post Market Surveillance (PMS) study are to evaluate the treatment effect of pramipexole on Restless Legs Syndrome (RLS) severity as measured by International Restless Legs Rating Scale and Global Clinical Impression - Improvement, to evaluate the time to reaching maintenance dose of pramipexole
Conditions
- Restless Legs Syndrome
Interventions
Sifrol® (pramipexole dihydrochloride)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency Analysis for Baseline Pattern of RLS SymptomsTime frame: Baseline
- Change in Total Scores of IRLS (International Restless Legs Rating Scale)Time frame: Baseline and final visit (week12)
- Change in Global Clinical Impression - Improvement (CGI-I) ScaleTime frame: baseline and final visit (week 12)
- Frequency of Adverse EventsTime frame: Up to 16 weeks
- Correlation of the Change in IRLS at End of Titration and at Final VisitTime frame: Up to 12 weeks
Locations
127 sites in 1 country. Site status is shown where the registry gives one.
Boehringer Ingelheim Investigational Site
Absam, Austria
Boehringer Ingelheim Investigational Site
Absdorf, Austria
Boehringer Ingelheim Investigational Site
Afritz, Austria
Boehringer Ingelheim Investigational Site
Alkoven, Austria
Boehringer Ingelheim Investigational Site
Altenmarkt/Zauchensee, Austria
Boehringer Ingelheim Investigational Site
Anif, Austria
Boehringer Ingelheim Investigational Site
Au, Austria
Boehringer Ingelheim Investigational Site
Bad Goisern am Hallstättersee, Austria
Boehringer Ingelheim Investigational Site
Bad Schallerbach, Austria
Boehringer Ingelheim Investigational Site
Bad Vöslau, Austria
Boehringer Ingelheim Investigational Site
Baden, Austria
Boehringer Ingelheim Investigational Site
Bärnbach, Austria
Boehringer Ingelheim Investigational Site
Bleiburg, Austria
Boehringer Ingelheim Investigational Site
Bludenz, Austria
Boehringer Ingelheim Investigational Site
Bregenz, Austria
Boehringer Ingelheim Investigational Site
Bruck A.d. Mur, Austria
Boehringer Ingelheim Investigational Site
Deutschkreutz, Austria
Boehringer Ingelheim Investigational Site
Deutschlandsberg, Austria
Boehringer Ingelheim Investigational Site
Dornbirn, Austria
Boehringer Ingelheim Investigational Site
Ebensee, Austria
Boehringer Ingelheim Investigational Site
Faak am See, Austria
Boehringer Ingelheim Investigational Site
Ferlach, Austria
Boehringer Ingelheim Investigational Site
Fieberbrunn, Austria
Boehringer Ingelheim Investigational Site
Filzmoos, Austria
Boehringer Ingelheim Investigational Site
Fischamend, Austria
Boehringer Ingelheim Investigational Site
Fohnsdorf, Austria
Boehringer Ingelheim Investigational Site
Fritzens, Austria
Boehringer Ingelheim Investigational Site
Gallizien, Austria
Boehringer Ingelheim Investigational Site
Gallspach, Austria
Boehringer Ingelheim Investigational Site
Gaspoldshofen, Austria
Boehringer Ingelheim Investigational Site
Gerasdorf bei Wien, Austria
Boehringer Ingelheim Investigational Site
Gloggnitz, Austria
Boehringer Ingelheim Investigational Site
Gmunden, Austria
Boehringer Ingelheim Investigational Site
Grafenstein, Austria
Boehringer Ingelheim Investigational Site
Graz, Austria
Boehringer Ingelheim Investigational Site
Großklein, Austria
Boehringer Ingelheim Investigational Site
Grünbach, Austria
Boehringer Ingelheim Investigational Site
Haid, Austria
Boehringer Ingelheim Investigational Site
Halbturn, Austria
Boehringer Ingelheim Investigational Site
Hall in Tirol, Austria
Showing 40 of 127 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.